Search

everythinglearnresearchcommunity

for

Search:↓

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

The symposium concluded that hair growth involves complex processes, including the hair follicle life cycle, the role of the dermal papilla, hair strength, pigmentation, and the impact of diseases and treatments like minoxidil on hair and skin.

Cyclosporine cleared a woman's resistant skin condition quickly and kept it away for over a year.

The study suggests computer-assisted analysis of scalp biopsies could improve hair loss diagnosis but needs more validation.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Children's hair loss can be caused by many factors, including autoimmune diseases, emotional stress, genetics, and infections, with treatment and prognosis varying.

We need better treatments for hair loss, and while test-tube methods are helpful, they can't fully replace animal tests for evaluating new hair growth treatments.

The document concludes that understanding hair structure is key to diagnosing hair abnormalities and recommends gentle hair care for management.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

A man had temporary hair loss from radiation during a medical procedure but regrew his hair after treatment with minoxidil lotion.

Alopecia areata causes hair loss with varied treatment responses and frequent relapses.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Alopecia areata involves immune response and gene changes affecting hair loss.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

Alopecia areata has a complex genetic basis that was not fully understood as of 2001.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

The letter suggests that psychiatric issues, not a sleep disorder, were likely the cause of a patient's self-inflicted leg ulcers.

Stress can cause a type of hair loss in mice lacking the CCHCR1 gene.

Yellow dots and short vellus hairs are the most common signs of Alopecia Areata (AA), and trichoscopy can help diagnose AA and track treatment progress.

COVID-19 can cause hair loss starting as early as 18 days after infection.

Different types of persistent hair loss after chemotherapy respond differently to treatments.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

The document concludes that certain rats and mice are useful for studying hair loss in humans and testing treatments.

Certain cells outside the hair follicle's bulge area can quickly regenerate damaged hair follicles, potentially helping to reduce hair loss from cancer treatments.